Sg Americas Securities, LLC Celldex Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 20,316 shares of CLDX stock, worth $544,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,316

Previous 9,044 124.64%

Holding current value

$544,671

Previous $335,000 106.27%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$32.06 - $44.56 $361,380 - $502,280	11,272 Added 124.64%	20,316 $691,000
Q2 2024 Jul 12, 2024	SELL	$32.76 - $42.56 $367,960 - $478,033	-11,232 Reduced 55.4%	9,044 $335,000
Q1 2024 May 06, 2024	SELL	$35.22 - $51.88 $908,922 - $1.34 Million	-25,807 Reduced 56.0%	20,276 $851,000
Q4 2023 Jan 12, 2024	SELL	$22.61 - $40.65 $721,892 - $1.3 Million	-31,928 Reduced 40.93%	46,083 $1.83 Million
Q3 2023 Oct 13, 2023	BUY	$25.45 - $37.46 $1.86 Million - $2.74 Million	73,079 Added 1481.73%	78,011 $2.15 Million
Q2 2023 Jul 10, 2023	SELL	$30.29 - $38.28 $165,292 - $208,893	-5,457 Reduced 52.53%	4,932 $167,000
Q1 2023 Apr 28, 2023	BUY	$34.78 - $47.43 $124,755 - $170,131	3,587 Added 52.73%	10,389 $374,000
Q4 2022 Feb 02, 2023	SELL	$27.78 - $45.38 $174,069 - $284,351	-6,266 Reduced 47.95%	6,802 $303,000
Q3 2022 Oct 31, 2022	SELL	$22.7 - $37.57 $968,994 - $1.6 Million	-42,687 Reduced 76.56%	13,068 $367,000
Q2 2022 Jul 29, 2022	BUY	$20.5 - $37.33 $856,797 - $1.56 Million	41,795 Added 299.39%	55,755 $1.5 Million
Q1 2022 Apr 29, 2022	BUY	$27.64 - $39.32 $107,049 - $152,286	3,873 Added 38.4%	13,960 $475,000
Q4 2021 Feb 07, 2022	SELL	$35.68 - $56.27 $338,496 - $533,833	-9,487 Reduced 48.47%	10,087 $390,000
Q3 2021 Nov 01, 2021	BUY	$28.95 - $55.99 $566,667 - $1.1 Million	19,574 New	19,574 $1.06 Million
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $406,417 - $750,830	-25,103 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$14.99 - $22.75 $376,293 - $571,093	25,103 New	25,103 $440,000

Others Institutions Holding CLDX

# of Institutions

206

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.25B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Celldex Therapeutics, Inc. Transaction History